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and Mrutyunjay Suar1*Abstract
Background: Salmonella enterica serovar Enteritidis infections are known to exhibit worldwide prevalence with
increased morbidity and mortality. The conventional strategies like antibiotic therapy and vaccination have not only
proved to be of sub-optimal efficacy but also led to the development of multidrug resistant strains of Salmonella.
Antimicrobial activities of probiotics against various enteropathogens and other health promoting effects have
assumed greater significance in recent years. The present study aims to evaluate the efficacy of a Lactobacillus
plantarum strain (KSBT 56, isolated from a traditional food product of India), in preventing Salmonella enterica
serovar Enteritidis growth and pathogenicity in vitro.
Methods and results: The cell free culture supernatant (CFCS) of KSBT 56 strain notably inhibited the growth of
Salmonella Enteritidis without affecting the growth of other gram-positive lactic acid bacteria. The isolated KSBT 56
strain produces lactic acid similar to other standard probiotic strains like Lactobacillus plantarum MTCC 1407. The
free radical production by KSBT 56 strain was studied by using sodC mutant of S. Enteritidis, which exhibited
reduced growth in the presence of CFCS of the KSBT 56 strain, indicating the inhibitory activity of free radicals on
the growth of S. Enteritidis. Our results also showed a significant reduction in the biofilm forming ability of
Salmonella Enteritidis in the presence of the KSBT 56 strain (2 log cfu/ml, p = 0.01). Further, the anti-infective
characteristics of KSBT 56 strain was validated by gentamicin protection assay which revealed 80% reduction in the
invasion of Salmonella Enteritidis to HCT-116 cell line (Salmonella Enteritidis and KSBT 56 in a 1:1 ratio) and delayed
addition of Salmonella Enteritidis by 1 h. Similarly, the reduced adhesion of Salmonella to the HCT-116 cells was
observed along with the down regulation of hilA gene of Salmonella Pathogenicity Island 1 (SPI1) indicating that
they might have acted synergistically to decrease the invasion of the pathogen into the cell line.
Conclusions: KSBT 56 strain effectively inhibited the growth, invasion and the biofilm forming ability of Salmonella
Enteritidis without inhibiting the growth of other Lactobacillus strains. Overall, our result suggested that KSBT 56 can
be used as a potential probiotic strain with considerable beneficial effects on the host.
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Salmonella enterica is a major food borne pathogen and
one of the leading causes of serious illness ranging from
acute gastroenteritis to systemic infections like typhoid. In-
fections with non typhoidal serovars of Salmonella enterica,
predominantly Salmonella Enteritidis (S. Enteritidis) and
S. Typhimurium are more frequent and occur in both de-
veloping and industrialized nations. These infections are
primarily associated with gastrointestinal inflammation and
diarrhea and are generally self-limiting [1]. The established
strategies to combat Salmonella infections include vaccin-
ation and the use of antibiotics. However, the frequent and
prolonged use of antibiotics not only leads to increasing
antibiotic resistance among Salmonella serovars but also
alters the intestinal commensal flora [2]. The emergence
of multidrug resistant strains and the suboptimal effi-
cacy of currently available vaccines have necessitated
the search for alternative therapies against Salmonella
infections [3-5]. One such promising alternative is the
possible therapeutic use of probiotics against various
enteropathogens [6-8].
Probiotics are defined as “live microorganisms which
when administered in adequate amounts confer a health
benefit on the host” [3]. The possible mechanisms by
which probiotics may inhibit enteric pathogens include
modification of the host intestinal environment and
immune system, competition for nutritional substrates
as well as sites of adhesion on intestinal epithelial cells,
secretion of antimicrobial compounds and inactivation
of toxins [4]. Earlier studies have reported the use of
probiotics in the prevention and treatment of gastrointes-
tinal infections caused by Salmonella [5]. However, the
underlying molecular mechanisms by which probiotics
offer protection against gastrointestinal pathogens are not
fully elucidated [9-11]. The most extensively studied
probiotic strains are reported from genera Lactobacillus
and Bifidobacterium, which are also included in many
functional foods and dietary supplements [12,13]. The
beneficial effects of the probiotics are known to be genus,
species and strain specific and a particular probiotic strain
is found to be active against selected enteric pathogen
only [9,14,15]. The selection of a microbial strain is there-
fore, an important criterion to consider it as a probiotic
for its effective and potential therapeutic use.
Food based probiotics have assumed greater signifi-
cance in recent years as different food products can
harbor native and beneficial Lactobacilli and thus can
be used for both nutritional and therapeutic purposes.
Traditional Indian foods are well known for their
unique fermentation style and can be used as a source
of potentially beneficial probiotics. The antibacterial
mechanisms of action of these Lactobacillus strains, es-
pecially the production of nonbacteriocin molecules,
have not been extensively studied. The main objectiveof the present study is to determine the efficacy of an
isolated probiotic strain in preventing S. Enteritidis in-
fections. Further, the mechanism of antimicrobial acti-
vity was assessed in order to establish it as a potential
probiotic strain, specifically active against S. Enteritidis,
which contributes to major Salmonella infections.Results
Effect of CFCS on viability of S. Enteritidis
The CFCS of Lactobacillus strains are known to have
antimicrobial effects against enteric pathogens [14]. In
this study, the effect of CFCS of KSBT 56 strain on S.
Enteritidis viability was assessed using flow cytometric
analysis. The dead bacterial cells were shown in the
propidium iodide quadrant (Figure 1). Different concen-
trations (3%, 5%, 7%, 9% and 11%) of CFCS of KSBT 56
were used to study its effect on the viability of S.
Enteritidis. The inhibition of S. Enteritidis increased with
increasing concentration of the CFCS of the probiotic
strain. Effective killing of S. Enteritidis (89.6%) was ob-
served with 11% of CFCS after 4 h. Similarly, CFCS was
also found to be effective against other pathogens such as
E. coli, S. Typhi and S. Typhimurium (data not shown).Effect of CFCS of the KSBT 56 on other Lactobacillus
strains
Probiotics should be able to selectively inhibit pathogens
while not having any deleterious effect on the normal
gut flora, to be considered as safe for consumption. The
effect of CFCS of the KSBT 56 strain was studied by
incubating different Lactobacillus strains with the pro-
biotic CFCS. No significant differences were observed in
the viability of the standard Lactobacillus strains in the
presence or absence of the CFCS (Figure 2). The results
partly confirm the safety of KSBT 56 as a probiotic
strain as it does not have a deleterious effect on the nor-
mal commensal gut flora.Production of lactic acid by KSBT 56
Lactic acid is one of the important factors produced by
Lactobacillus strains which inhibit various pathogens at a
specific concentration. For example, the standard Lac-
tobacillus strain Lactobacillus plantarum (L. plantarum)
MTCC 1407 inhibits pathogens like Salmonella and
Shigella, at a concentration of 6.0 mM lactic acid pro-
duced at 6 h. In the present study, the lactic acid concen-
tration of KSBT 56 was estimated to be 5 mM at 6 h,
which was comparable to that of L. plantarum MTCC
1407. The total lactic acid concentration in the CFCS of
KSBT 56 was also estimated to be 5mM at 6h, indicating
its antimicrobial property.
Figure 1 Flow cytometer analysis of live/dead S. Enteritidis grown in the CFCS of KSBT 56 strain. S. Enteritidis expressing GFP are shown
in Q3 in FITC channel. Propidium Iodide positive S. Enteritidis is shown in Q1 in PE-A channel. S. Enteritidis with compromised membrane
expressing both GFP and propidium Iodide are seen in Q2. A. Untreated S. Enteritidis is shown in Q4. B. S. Enteritidis treated with 3% CFCS shows
86.6% of the population expressing GFP. C. S. Enteritidis treated with 5% CFCS has 87.8% of the population expressing GFP. D. S. Enteritidis
treated with 7% CFCS shows 10.5% live S. Enteritidis expressing GFP. E. S. Enteritidis treated with 9% CFCS shows 1.08% live Salmonella in Q3 F. S.
Enteritidis treated with 11% CFCS shows 0.1% live S. Enteritidis in the GFP-positive quadrant (Q3).
Figure 2 The growth of different Lactobacillus strain in the presence of CFCS of KSBT 56 strain. The absorbance of the cultures at 600 nm
is plotted on the y-axis. The growth of different Lactobacillus strains was analysed by comparing absorbance at 0 h and 24 h of growth in
presence of CFCS of KSBT 56.
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Figure 4 Inhibition of biofilm formation of S. Enteritidis by the
KSBT 56 strain. The biofilm forming colonies of S. Enteritidis were
enumerated on streptomycin LB Agar plates. The KSBT 56 bacterial
culture was added to S. Enteritidis either simultaneously (0 h)
indicated by (+) or at a time delay of 1 h. The absence of KSBT 56 is
denoted by (−). KSBT 56 bacterial culture is plated on streptomycin
LB Agar plates as control.
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S. Enteritidis
The antimicrobial activity of the free radicals produced by
KSBT 56 strain against S. Enteritidis was determined
by using superoxide dismutase (sodC) gene knock out
mutant. A sodC mutant is known for its increased suscep-
tibility to free radicals as compared to the wild type (WT)
strain. Results showed that S. Enteritidis harboring sodC
mutation exhibited reduced growth in the presence of
CFCS of the KSBT 56 strain in the co-culture experiment
(Figure 3). As compared to the S. Enteritidis (WT) strain,
ΔsodC mutant was sensitive to CFCS treatment showing
a 2-log decrease in its viability on the addition of CFCS
(p = 0.01). This indicates that S. Enteritidis is susceptible
to the free radicals produced by the KSBT 56 strain.
Inhibitory effect of KSBT 56 on biofilm formation ability
of S. Enteritidis
The effect of KSBT 56 on the biofilm forming ability of
S. Enteritidis was determined by co-culture experiment
and by delayed addition of Salmonella to KSBT 56 strain
in a 96 well plate. Biofilm formation was confirmed by
crystal violet staining (data not shown). The cfu recovered
from the biofilm formed by Salmonella in a 96 well plate
were plated on LB agar plates in different dilutions. The
simultaneous addition of S. Enteritidis with the KSBT 56
strain did not show any significant inhibition of the bio-
film formation by S. Enteritidis. However, on the delayed
addition (1 h) of S. Enteritidis to the culture containing
the probiotic strain, a 2-log decrease in biofilm forming
colonies of Salmonella was observed (p = 0.01) (Figure 4).
Inhibition of invasion of S. Enteritidis by KSBT 56
To determine the inhibitory effect of KSBT 56 on invasion
of S. Enteritidis, standard gentamicin protection assay wasFigure 3 Inhibition of growth of S. Enteritidis WT and ΔsodC mutant
Enteritidis (SEn) WT or a mutant strain deficient of sodC gene (ΔsodC) were
with live KSBT 56 bacterial culture. The cfu was enumerated by plating on
or KSBT 56 is indicated by (+) and the absence is indicated by (−). The gro
presence of CFCS or live KSBT 56 strain.performed with simultaneous and delayed addition of
S. Enteritidis strain to HCT-116 cell line. Gentamicin kills
the extracellular bacteria while the intracellular bacteria
are plated on LB agar plates and cfu enumerated. Reduced
invasion (by 40%) of S. Enteritidis was observed on simul-
taneous addition of the pathogen and the probiotic strain
in the ratio of 1:1 (Figure 5A). Further, the invasion effi-
ciency of S. Enteritidis was significantly reduced by 80%
on addition of KSBT 56 strain 1 h prior to the addition of
S. Enteritidis as compared to the control (S. Enteritidis
only) (p = 0.0012). Similarly, the invasion of Salmonella
was reduced by 23% on co-incubation with CFCS of
KSBT 56 strain and by 28% on delayed addition of S.in the presence of CFCS (A) of KSBT 56 or live KSBT 56 (B). A. S.
co-incubated with CFCS. B. The above groups were also co-incubated
LB agar plates supplemented with streptomycin. The presence of CFCS
wth of ΔsodC is compared with S. Enteritidis WT strain grown in the
Figure 5 Effect of KSBT 56 on invasion of S. Enteritidis (A) and effect of CFCS of KSBT 56 on invasion of S. Enteritidis to HCT-116 cells.
A. Gentamicin protection assay was performed to determine the invasion of S. Enteritidis into the HCT-116 cell line in the presence (+) or
absence (−) of KSBT 56 strain. The pathogen and the KSBT 56 strain were either co-infected together into the cell line (0 h) or the pathogen was
added at a time delay of (1 h). B. The effect of CFCS on invasion of S. Enteritidis was determined by co-incubating S. Enteritidis with the CFCS of
KSBT 56 in 24- well tissue culture plate seeded with HCT-116 cell line. S. Enteritidis was also cultured with CFCS for 1 h before infection of
HCT-116 cells. L. plantarum MTCC 1407 was taken as a reference strain. The invasion of S. Enteritidis to HCT-116 cells is taken as control.
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for 1 h (Figure 5B). The confocal images provide further
conclusive evidence of the reduced invasion of S.
Enteritidis and adherence of the KSBT 56 strain to the
HCT-116 cell line (Figure 6A-D).Adhesion of S. Enteritidis to HCT-116 cell line in the
presence or absence of KSBT 56
Probiotics are known to adhere to intestinal epithelial cells
thereby competitively excluding the adhesion of patho-
gens. The adhesion of S. Enteritidis to HCT-116 colon
Figure 6 Confocal images of Salmonella invasion (A-D) and Expression of hilA gene by RT-PCR (E). Confocal images were taken at 63X
magnification using Leica CLSM. The membrane of HCT-116 cell lines were stained with plasma red dye and S. Enteritidis was tagged with GFP.
The KSBT 56 strain was observed in phase contrast. A. S. Enteritidis invasion into HCT-116 in the absence of KSBT 56 strain. B. S. Enteritidis
coinfected with KSBT 56 strain into HCT-116 cell line shows reduced invasion of S. Enteritidis. C. Delayed addition of S. Enteritidis after addition of
KSBT 56 strain by 1 h further reduces the invasion of Salmonella into the cell lines. D. Merged image of panel C with phase contrast shows KSBT
56 adhering to HCT-116. E. RT-PCR analysis of hilA gene of S. Enteritidis grown in increasing concentration of CFCS of KSBT 56 strain. L. plantarum
MTCC 1407 is a reference strain. The fold change in the expression of hilA gene is compared to S. Enteritidis WT (Untreated). SEn refers to S.
Enteritidis and LP refers to L. plantarum MTCC 1407.
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layed addition of S. Enteritidis and KSBT 56 strain. No
significant reduction in the adhesion of the S. Enteritidis
to HCT-116 cells was observed on simultaneous addition
of the probiotic and the pathogenic strain. However, the
adhesion of S. Enteritidis to HCT-116 cell line was signifi-
cantly reduced (p=0.01) on the delayed infection of
Salmonella by 1 h after the addition of the KSBT 56 strain.
The CFCS of KSBT 56 strain did not decrease the adhe-
sion of S. Enteritidis to HCT-116 cell line significantly
either on co-incubation or on delayed addition of the
pathogen, after 1 h of incubation with CFCS of KSBT 56
strain. The percentage of adhesion of KSBT 56 and
S. Enteritidis is shown in Table 1.
Effect of CFCS on hilA (SPI1) expression
SPI1 encodes genes which are involved in the invasion
of Salmonella into intestinal epithelial cells. The hilA
gene, a major transcriptional regulator of SPI1, is report-
edly down regulated in the presence of probiotic CFCSTable 1 Adhesion of S. Enteritidis and KSBT 56 to HCT-116 ce
Infection of HCT-116 cell line
S. Enteritidis WT : KSBT 56 (1:1)
S. Enteritidis WT : KSBT 56 (1:1) delayed addition of S. Enteritidis by 1 h
S. Enteritidis WT
KSBT 56
S. Enteritidis + CFCS of KSBT 56
S. Enteritidis incubated with CFCS of KSBT 56 for 1h
The values represent the S.D of 3 different experiments. NT is not tested. SEn is Sal
The significant differences between a and b were calculated using t-test.[16]. RT-PCR was used to study hilA gene expression in
the presence of varying concentrations of CFCS of KSBT
56 strain. The results showed that with the increasing
concentration of CFCS of the KSBT 56 strain, hilA gene
expression was consistently down regulated. The hilA
gene expression in the presence of CFCS of KSBT 56
strain is shown in Figure 6E. Thus, apart from reduced
adhesion, the down regulation of hilA gene was also
responsible for the reduced invasion of S. Enteritidis to
HCT-116 cells as shown in Figure 6A-D.
Discussion
Probiotics have been successfully used for the prevention
and treatment of various gastrointestinal diseases of
human and animals [17]. The beneficial Lactobacillus
strains present in the fermented dairy products are
known to have a nutritional and therapeutic effect on
human health [18]. Several in vivo and in vitro studies
have demonstrated that probiotics can inhibit Shigella
dysenteriae [19], Salmonella [5] and Clostridium difficilell line
Adhesion percentage of SEn Adhesion percentage of KSBT 56
11.68% ± 3.68 6.43% ± 1.69
7.7% ± 1.09a 7.53% ± 2.4
12.08% ± 1.51b N.T
N.T 8.0% ± 2.34
10.35% ± 3.50 N.T
10.06 ±1.06 N. T
monella Enteritidis.
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mode of action has largely remained unanswered. The
present study, therefore aimed to understand the under-
lying mechanism of action of a novel Lactobacillus strain
isolated from a fermented milk product.
In this study, the CFCS of the isolated KSBT 56 strain,
inhibited S. Enteritidis growth in in vitro culture system
and the live KSBT 56 culture effectively prevented its
attachment and invasion to the colon epithelial cell lines
(HCT-116). Flow-cytometric dead/live staining analysis
is a sensitive measure of bacterial cell death. Therefore
the technique has been used in our study to assess
S. Enteritidis viability when cultured in the presence of
CFCS of KSBT 56 strain. By increasing the concentra-
tion of CFCS, viable counts of S. Enteritidis decreased
consistently, but at low concentration, a significant per-
centage of S. Enteritidis were also observed showing
positive for both GFP and propidium iodide. This is
probably because of their compromised status of the
membrane integrity. Similarly, no deleterious effects
were observed on the other commensal gut flora further
establishing its safety profile. Previous studies have
reported that CFCS of L. plantarum induces complete
inhibition of Salmonella growth, which was mainly at-
tributed to the lactic acid production by the probiotic
strain [11,21]. CFCS of probiotic Lactobacillus strains re-
portedly contain several antimicrobial compounds [22],
lactic and non-lactic acids as well as hydrogen peroxide
which can kill various enteropathogens [23]. Earlier
studies have also established that lactic acid production
by probiotic Lactobacillus strains is a key mechanism
involved in inhibiting bacterial growth [24,25]. In the
present study, the lactic acid produced by the KSBT 56
strain was comparable to that of the reference strain L.
plantarum and therefore we suggest that the inhibitory
activity shown against S. Enteritidis could be partly due
to the production of lactic acid in the CFCS. Alterna-
tively, the mechanism of the antimicrobial activity of pro-
biotic Lactobacillus strains might also include production
of other non-lactic acid components and peroxide radicals
[17,25]. Furthermore, to study the effect of free radical
produced by the strain KSBT 56, sodC mutation was in-
corporated in S. Enteritidis. Results showed the increased
inhibition of growth of ΔsodC mutant when cultured in
the presence of CFCS, indicating that free radicals might
be generated by the KSBT 56 strain.
One of the reasons Lactobacilli have been widely studied
is because of their remarkable ability to inhibit the growth
of various pathogens by producing antimicrobial com-
pounds and inhibiting biofilm formation by various patho-
gens [26]. The inhibitory effect of Lactobacillus supernatant
on biofilm formation by K. pneumonia was shown in a
recent study [27]. Similarly, in another related study, the in-
hibitory effect of L. fermentum supernatant was observedon the Klebsiella growth and biofilm formation [28]. In the
present study, similar results were observed, where the
biofilm forming ability of the pathogen was reduced on
delayed addition of Salmonella, in the presence of KSBT
56 strain.
One of the key steps identified in the pathogenesis of
intestinal pathogens is their ability to attach to the
surfaces of intestinal epithelial cells via fimbriae or pili,
present on the bacterial cell surface [29]. The subse-
quent step in Salmonella pathogenesis after attachment
is the invasion of intestinal epithelial cells. In the present
work, colon epithelial cell line, HCT-116 was used to
study the adherence and invasion of S. Enteritidis. Our
results demonstrated a significant reduction in the
adherence of Salmonella to the HCT-116 cell lines when
incubated with the KSBT 56 strain. Similarly, invasion of
S. Enteritidis to HCT-116 cell line was noticeably re-
duced both in the co-culture experiment and on the de-
layed addition of Salmonella. The significant reduction
in invasion of S. Enteritidis on delayed addition of the
pathogen may be due to the initial attachment of KSBT
56 strain to colon epithelial cells further preventing the
attachment of Salmonella. Previous studies have also
reported reduced adhesion of pathogens in the presence
of probiotic strains due to competitive exclusion of the
pathogens [30]. However, in the present study we ob-
served reduced invasion of Salmonella to HCT-116 cells
by 40% in co-culture experiment, although there was no
significant difference in the adhesion of KSBT 56. The
CFCS of KSBT 56 strain also inhibited the invasion of
Salmonella, while not having any significant effect on
the adhesion of the pathogen to HCT-116 cell line.
These results collectively indicate the involvement of an
alternative mechanism besides the competitive exclusion
of the pathogen, thereby reducing the invasion of S.
Enteritidis into colon epithelial cell lines.
The invasion of intestinal epithelial cells by Salmonella
requires a set of genes present on the SPI1, the expres-
sion of which is tightly regulated by hilA [31]. Previous
studies have reported that various probiotic components
down regulate hilA gene expression in S. Typhimurium
thereby preventing its invasion into intestinal epithelial
cells [16,31-33]. Our data was also in agreement with
these findings and showed down regulation of hilA gene
expression of S. Enteritidis in the presence of CFCS of
KSBT 56. Based on these results, we proposed that the
CFCS of the KSBT 56 strain might secrete components
which can down regulate virulence related genes in S.
Enteritidis. The reduced expression of genes involved
in invasion is therefore one of the important mecha-
nisms which contributes to the antimicrobial effect of
probiotics on intestinal pathogens. Overall, the results
obtained from this study indicate that, the KSBT 56
strain isolated from fermented milk product can serve as
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ties. The in vitro data suggests that the isolated KSBT 56
strain might exert its beneficial effect via multifactorial
mechanisms, which might act synergistically to antagonize
intestinal pathogens. In the present study, we have pro-
vided key insights into possible mechanism of action of
the KSBT 56 strain against S. Enteritidis and established
its beneficial properties as a probiotic strain, which can be
further exploited for commercial purposes.Conclusions
Overall results from this study suggested that KSBT 56
strain showed a potent antimicrobial activity against
S. Enteritidis. The KSBT 56 strain was found to consi-
derably inhibit the growth, adherence and invasion of
S. Enteritidis. Similarly, the biofilm forming ability of
S. Enteritidis was substantially reduced by the KSBT 56
strain. The structures of the nonbacteriocin and non-
lactic acid components and the specificity of their antag-
onistic activity against enteroinvasive and enterovirulent
S. Enteritidis strain remain an important area of future
research.Methods
Bacterial strains and culture conditions
KSBT 56 strain was isolated from dahi chenna (traditional
fermented milk product) obtained from a local household.
L. plantarum MTCC 1407 was used as a reference strain.
Lactobacillus strains were grown in deMan, Rogosa and
Sharpe (MRS) (HiMedia Pvt. Ltd., Mumbai) broth under
aerobic conditions at 37°C for 18 h. S. Enteritidis was
grown for 12 h and subcultured in Luria-Bertani LB
(HiMedia Pvt. Ltd., Mumbai) at 37°C and used until they
reached the early log phase of growth. For, biofilm, adhe-
sion and invasion assays, equivalent cfu/ml counts of live
KSBT 56 and S. Enteritidis cultures were used to deter-
mine the competitive exclusion of the pathogen and a
sub-lethal dose of CFCS was used to determine the effect
of CFCS on adhesion and invasion of the pathogen. Pre-
liminary experiments confirmed M-17 medium to be an
appropriate medium for co-culture experiments with S.
Enteritidis and the live KSBT 56 strain. The bacterial
strains used in this study are listed in Table 2.Table 2 Bacterial strains used in the study
Strain name Culture collection number
S. Enteritidis P125109 ATCC 13076
Lactobacillus plantarum MTCC 1407
KSBT 56 NCDC 681
Lactobacillus fermenti ATCC 9338
Lactobacillus brevis ATCC 367
Lactobacillus casei ATCC 9595Preparation of cell free culture supernatant
CFCS of the probiotic strains are generally preferred
over live probiotic bacteria for in vitro inhibition assays
because probiotics have longer lag phase and generation
time than S. Enteritidis. Further, Salmonella growth
would be favoured before the probiotic strain could
express its antimicrobial activity. Therefore, the CFCS of
KSBT 56 strain was taken for the inhibition assays
against S. Enteritidis. The CFCS of KSBT 56 strain was
prepared as described by Truusalu et al. [6]. Briefly, cells
were grown overnight in MRS broth for 18 h. KSBT 56
culture was centrifuged at 15000 rpm for 20 min and CFCS
was filter-sterilized using 0.22-μm-pore-size millipore filters
(Millipore Co., Italy).Cell cultures
HCT-116 colon cells were grown in Dulbecco’s modified
Eagle Medium (DMEM) (HiMedia Pvt. Ltd., Mumbai)
supplemented with 10% inactivated fetal bovine serum
(FBS), glutamine (1.5 mM/500 ml) and penicillin (0.2 U/ml),
streptomycin (0.1mg/ml). Cells were cultured at 37°C in
an atmosphere of 5% CO2 and 95% air.Effect of CFCS on viability of Salmonella
S. Enteritidis culture transformed with pCJLA plasmid
expressing green fluorescent protein (GFP) was grown
overnight and subcultured for 2 h. CFCS of the KSBT 56
strain was added in increasing concentration to the S.
Enteritidis culture in an early exponential phase and in-
cubated further for 3 h. The bacterial cells were pelleted
by centrifugation (1500 rpm for 5 mins) washed and
resuspended in phosphate-buffered saline (PBS) and
stained with propidium iodide. Flow cytometric analysis
of the dead and live S. Enteritidis was carried out
to analyze the inhibitory activity of the CFCS of the
KSBT 56 strain. Flow cytometric measurements were
performed using a FACScanto™ II cytometer (Becton–
Dickinson, Erembodegem, Belgium). First, unstained S.
Enteritidis WT strains were used to set the photo multi-
plier tube (PMT) voltage of flow cytometer and distin-
guish bacteria from debris. Subsequently, S. Enteritidis
expressing GFP and those stained with propidium iodide
were detected on separate channels after setting theReference or source
[36]
A kind gift from Dr. Knut Heller
Isolated from dahi chenna, a traditional food product of India
ATCC
ATCC
A kind gift from Dr. Peter Leuthy
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Flowjo software (Vx 10.0.6 beta).
Effect of CFCS of the isolated KSBT 56 strain on other
Lactobacillus strains
To determine the effect of the CFCS on other probiotic
strains, overnight culture of Lactobacillus casei, Lactoba-
cillus fermenti and Lactobacillus brevis were co-cultured
with the CFCS of the probiotic strain at 37°C at minimum
inhibitory concentration (11% CFCS of KSBT 56) deter-
mined for S. Enteritidis earlier. The analysis of growth was
based on OD measurements at 600 nm determined at
baseline and after 24 h of incubation. Each experiment
was performed in triplicates and repeated thrice.
Determination of lactic acid concentration
Lactic acid is the known component secreted by probiotic
strains involved in the inhibition of enterocolitic patho-
gens. To determine whether the isolated KSBT 56 strain
was producing lactic acid equivalent to other reference
strains like L. plantarum MTCC 1407, a commercially
available D- and L- Lactic acid estimation kit (Megazyme,
Ireland) was used. After culturing the KSBT 56 and the
reference strain for 6 h at 37°C, lactic acid concentration
was determined by D- and L- Lactic acid estimation kit
according to manufacturers instructions. The lactic acid
concentration in the CFCS of KSBT 56 strain was also es-
timated in a similar manner, to determine if the inhibitory
activity of CFCS was due to the production of lactic acid.
Determination of the antimicrobial activity of free radicals
of the KSBT 56 strain
To determine the antimicrobial activity of the free radi-
cals produced by KSBT 56 strain against S. Enteritidis,
superoxide dismutase gene (sodC) knock out mutant
was used. sodC gene product is known to neutralize the
effect of free radicals and protect the bacteria. One step
inactivation method was used to construct a knock out
mutant of S. Enteritidis WT by deleting the sodC gene
[34]. Briefly, PCR primers providing homology to sodC
gene were used to knock out the gene. An easily curable,
low copy number plasmid pKD46 was used to facilitate
homologous recombination of the PCR primers with
homology to the sodC gene and template plasmidTable 3 Primers used in the study
Primer Sequence (5′ to 3′)
hilA F TTAACATGTCGCCAAACAGC
hilA R GCAAACTCCCGACGATGTAT
16s rRNA F GATCATGGCTCAGATTGAACGCTGGCGG
16s rRNA R CACCGCTACACCTGGAATTATACCCCCTC
FwKOSenSodC TTTTATGGGTAAAACGAAATTATGACGATATGG
RwKOSenSodC TTTTATTAATGGTATTTACGATACAACCAAAAAA(pKD4) carrying kanamycin resistance genes was trans-
formed into S. Enteritidis. The primers used in the study
are listed in Table 3. The mid log phase growth of S.
Enteritidis WT strain and sodC gene knockout mutant
was subcultured with 7% CFCS of the KSBT 56 strain,
for 4 h. It was determined in earlier experiment that 7%
CFCS of KSBT 56 strain considerably inhibited the
growth of S. Enteritidis. Similarly, both the strains were
co-cultured with the live KSBT 56 strain in M-17
medium. The cfu counts were enumerated by plating
appropriate dilutions of the above groups in LB agar
plates supplemented with streptomycin (50 μg/ml).
Effect of KSBT 56 strain on biofilm formation
The biofilm formation by S. Enteritidis was assessed by in-
cubating Salmonella with the probiotic strain in a 96 well
plate for 24 h. The experiment was performed in the
following groups: Group A: S. Enteritidis (108 cells/ml)
Group B: S. Enteritidis + KSBT 56 strain in the ratio of
1:1. Group C: S. Enteritidis was added 1 h after the
addition of the KSBT 56 strain in the ratio of 1:1. The
biofilm formation by S. Enteritidis in the above wells was
confirmed by crystal violet staining. The wells were
washed with PBS thrice. Subsequently, the biofilm forming
ability of Salmonella in various groups was determined
by plating and enumeration of adherent bacteria in 96
well plates on LB Agar supplemented with streptomycin
(50 μg/ml). The bacteria adhered to the wells forming
biofilms were scrapped and different dilutions were plated.
The plates were incubated at 37°C for 24 h and cfu count
recovered from the biofilms was determined. KSBT 56
strain was included as a control in the experiment.
Invasion assay
Invasion of S. Enteritidis to HCT-116 cell line was car-
ried out as previously described [35], with minor modifi-
cations. Briefly, HCT-116 cell line was maintained in
DMEM and passaged until confluence. The monolayer
cells were seeded on 24 well tissue culture plates (Nest
Biotech, China) and the confluent cells were washed
thrice with PBS. S. Enteritidis was grown overnight and
subcultured for 4 h in LB medium [36]. Bacterial cells
were washed and resuspended in DMEM and infected to
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in various groups. Group A: S. Enteritidis (1 × 108 cells/ml)
Group B: S. Enteritidis + KSBT 56 in the ratio of 1:1.
Group C: S. Enteritidis was added 1h after the addition of
the KSBT 56 strain in the ratio of 1:1. Group D: S.
Enteritidis + L. plantarum MTCC 1407 (1:1), was taken as
control. The plate was incubated for 50 min at 37°C in
CO2 incubator. HCT-116 cells were further incubated for
2 h in media containing gentamicin (100 μg/ml). Infected
cells were washed twice with PBS and lysed with 0.1%
Triton X-100. Dilutions of the resulting cell lysates were
plated on streptomycin LB Agar for determination of
intracellular bacterial counts. The above groups were also
processed for confocal microscopy for supportive evidence
of invasion assay. In a separate experiment, to determine
the effect of CFCS on Salmonella invasion, S. Enteritidis
was either co-incubated with CFCS (sub-lethal dose of 5%
of CFCS) or added after culturing with CFCS for 1 h, to a
24-well tissue culture plate seeded with HCT-116 cells
and standard gentamicin protection assay was performed
as described above.
Confocal microscopy
HCT-116 monolayers were incubated overnight at 37°C
in a humidified atmosphere at 5% CO2 in cell culture
medium without antibiotics before the addition of bac-
teria (MOI, 50:1). After incubation for 50 min in an
appropriate medium without fetal bovine serum, cells
were washed in PBS to remove non-invading bacteria.
The monolayer cells, prepared on glass coverslips, in 24
well tissue culture plates (Nest Biotech, China), were
fixed with 4% paraformaldehyde (PFA) and then stained
with plasma red dye (Invitrogen, Green Island, USA).
DAPI was used to stain the nucleus of HCT-116 cells. S.
Enteritidis containing plasmid pCJLA expressing GFP
was visualized using Confocal Laser Scanning Micro-
scope (CLSM, Leica). Z-stacking was used to distinguish
the internalized bacteria from the extracellular bacteria.
Adhesion assay
Adhesion assay was carried out as described previously
[14]. Each well of a 24-well tissue culture plate was seeded
with HCT-116 cells. 500 μl of DMEM without serum and
antibiotics was added to each well and incubated at 37°C
for 30 min. S. Enteritidis was grown overnight and the ex-
periment was performed in the following groups. Group
A: S. Enteritidis, 1 × 108 cfu/ml Group B: KSBT 56, 1 ×
108 cfu/ml Group C: S. Enteritidis: KSBT 56 (1:1) Group
D: S. Enteritidis added 1 h after the addition of KSBT 56.
Plate was incubated for 20 min at 4°C and the cells were
detached by adding Trypsin EDTA solution (HiMedia Pvt.
Ltd., Mumbai). The cells were further incubated for 15 min
at room temperature. The cell suspensions from each
group were plated at appropriate dilutions on MRS agarand LB Agar supplemented with streptomycin for diffe-
rential growth of KSBT 56 and S. Enteritidis. Similarly,
the effect of CFCS on adhesion was determined by co-
incubating S. Enteritidis with CFCS in 24-well tissue
culture plate seeded with HCT-116 cells or adding S.
Enteritidis to the wells after 1 h of subculturing with
CFCS, and adopting the above protocol of adhesion
assay. A sub lethal dose of 5% CFCS of KSBT 56 was
used for the assay.
Expression analysis of hilA gene (SPI1) by RT-PCR
Probiotics are known to down-regulate the expression of
virulence genes of S. Enteritidis present in both SPI1 and
SPI2. hilA gene is the major transcriptional regulator of
SPI1 and down-regulation of hilA reflects the down-
regulation of SPI1 genes required by S. Enteritidis for
successful invasion into host epithelial cells [37]. To
study the SPI1 regulation by KSBT 56, S. Enteritidis
culture was grown overnight and subcultured for 4 h in
the presence of increasing concentration of CFCS of the
KSBT 56. RNA was isolated using Real Genomics RNA
mini kit (Real Biotech Corporation, India) as per the
manufacturers instructions and reverse transcribed to
cDNA using cDNA synthesis kit (Fermentas, USA). The
relative quantification of hilA gene expression was ana-
lyzed by using 16s rRNA as the reference gene for both
treated and untreated S. Enteritidis culture. The RT-PCR
was carried out by using SYBR Green Master Mix
(Roche Applied Science, Mumbai, India). The PCR reac-
tion conditions consisted of initial denaturation at 95°C
for 5 min, 40 cycles of denaturation at 95°C for 15 sec,
followed by annealing at 54°C for 30 sec and extension
at 72°C for 45 sec. The primers used in the experiment
are listed in Table 3.
Statistical analysis
All the data represent the mean ± standard deviation of
three independent experiments. The significant differences
in the various experimental groups were determined by t-
test with the help of GraphPad Prism software version 5.
The flow cytometric data analysis was carried out by using
Flowjo V× 10.0.6 beta.
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